Wechselwirkungen · Prevenar 13
Prevenar 13 suspension for injection in single dose vial pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) · Abschnitt 4.5 · PDF-Seite 32
HOS-121884 · Präparat HOS-095437
Concomitant administration of Prevenar 13 and 23-valent pneumococcal polysaccharide vaccine has not been studied. In clinical studies when Prevenar 13 was given 1 year after 23-valent pneumococcal polysaccharide vaccine the immune responses were lower for all serotypes compared to when Prevenar 13 was given to subjects not previously immunised with 23-valent pneumococcal polysaccharide vaccine. The clinical significance of this is unknown.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-05T10:20:00Z · SHA-256 6a86f7a7aa34133091bc2ef414feeace046fcc5a28168dfdcb5f7fd2514bcdce · Passage 1beebf3b21a470a8d6c5d97a12d0ca094edad931e30e218cb313667f87ab246d · Zeichen 2893–3336 im Abschnitt